immunotherapy and the race to cure cancer
De som köpt den här boken har ofta också köpt Not the End of the World av Hannah Ritchie (häftad).
Köp båda 2 för 358 krOnly Graeber, one of America's greatest non-fiction writers, could take a subject so complex, dense and sprawling and turn it into a rollicking high-tension medical thriller. Masterful. -- Douglas Rogers, award-winning journalist and author of <i>The Last Resort</i> A gripping chronicle of the 100-year overnight success of immunotherapy. For myself and millions of other cancer survivors, The Breakthrough is a book of immense and essential hope. -- Michael Fitzgerald, co-founder and CEO of Submittable and author of <i>Radiant Days</i> There is no villain more ruthless than cancer, which has robbed us all of loved ones who had to endure untold suffering before they succumbed. But after decades of frustration and toil, scientists finally understand how to vanquish the disease by activating the human body's natural defences. The intimate stories behind this triumph lie at the heart of Charles Graeber's The Breakthrough, an expertly crafted and exhilarating account of life-saving ingenuity at its most dazzling. You will never encounter another book so incisive about the art of medical sleuthing, or so poetic about our innate drive to hold on to all that's beautiful in this world for as long as we can. -- Brendan I. Koerner, <i>Wired</i> contributing editor and author of <i>The Skies Belong to Us</i> Lucid and informed Graeber gives readers a basis for both understanding the challenges involved and for cautious optimism that a cure can be found. * <i>Publishers Weekly</i> * Graeber concisely reviews the science of cancer The risks of tinkering with an intricate immune system are obviously high, even perilous. But the potential reward is a cure. Exciting reading. * <i>Booklist</i> * Imagine a vaccine that could cure cancer. As this book reports, that possibility may not be far off [T]he book offers hope for more effective treatments in the near future. A readable survey of the emerging field of immunotherapy in cancer treatment. * <i>Kirkus</i> * In Mr Graebers hands, the evolution of immuno-oncology is both captivating and heartbreaking. -- David A. Shaywitz * The Wall Street Journal * Graebers writing is swift and clear, as if he can barely contain his enthusiasm for the subject and, in fact, he cant contain it ... One or two chapters are weighted down by talk of cell division and the like but, for the most part, Graeber paints vivid portraits of people who have cancer or are trying to conquer it ... a rare and thrilling thing: a hopeful, even inspiring, book about cancer. -- Chris Hewitt * Minneapolis Star Tribune * The extraordinary story of how medical research may finally have made the ultimate breakthrough a cure for cancer. -- Bianca Nogrady * Sydney Morning Herald * The new book by Charles Graeber, The Breakthrough: Immunotherapy and the Race to Cure Cancer, artfully traces the history of old and new developments that may have finally resulted in an actual cure for the most dreaded of all diseases. -- Mimi Swartz * The New York Times * Fascinating and engaging Written with the verve and tension of a medical thriller, Graeber vividly brings to life the scientists and physicians on the front-line battle with cancer and details in simple terms their efforts and breakthroughs. * Canberra Weekly * The Breakthrough not only provides good background and good understanding for patients, but is also a wonderful read, a book easily picked up but not easily put down I'd recommend it for any patient interested in immunology of cancer. -- Dr. James L. Gulley MD, PhD, Director of Medical Oncology, Chief of Immunology, National Cancer Institute (NCI), National Institutes of Health (NIH) Crisp and suspenseful ... an inspiring medical narrative. * BBC * Graeber does it again. He takes a complex topic this t
Charles Graeber is a contributing editor for Wired and a contributor to publications such as The New York Times, The New Yorker, GQ, Vogue, and many others. He has received many awards, and his work has been featured on NPR, CNN, the BBC, and numerous other media outlets.